Pomdoctor Ltd Class A Shares POM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
POMDOCTOR LIMITED Advances Strategic Evolution from Traffic Monetization to Value-Based Healthcare Payment
POMDOCTOR LIMITED Announces Receipt of Nasdaq Notifications Regarding Continued Listing Requirements
POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq
POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive Healthcare
POMDOCTOR LIMITED Announces Receipt of Nasdaq Staff Delisting Determination
POMDOCTOR LIMITED Accelerates AI-Enabled Chronic Disease Management and RWD Commercialization
POMDOCTOR LIMITED Highlights Differentiated "Hardware + AI + Payment" Healthcare Infrastructure Model
POMDOCTOR LIMITED to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
Trading Information
- Previous Close Price
- $1.39
- Day Range
- $1.37–1.39
- 52-Week Range
- $0.43–113.04
- Bid/Ask
- $1.36 / $1.50
- Shares Outstanding
- 2.78M
- Market Cap
- $3.81M
- Volume/Avg
- 3,915 / 2M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.02
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of its revenue is derived from the Pharmaceutical supply chain segment.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Stock Style Box
- Small Growth
- Total Number of Employees
- 165
- Website
- https://www.7lk.com
Valuation
Metric | POM |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.02 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | POM |
|---|---|
Quick Ratio | 0.30 |
Current Ratio | 0.35 |
Interest Coverage | −26.85 |
Quick Ratio
POM
Profitability
Metric | POM |
|---|---|
Return on Assets (Normalized) | −153.68% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
POM
Pharmaceutical Retailers Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| JD Health International Inc JDHIF | — | LOCK|F>M$ | $18B | |||
| JD Health International Inc ADR JDHIY | — | LOCK|D!?p | $18B | |||
| Alibaba Health Information Technology Ltd ADR ALBBY | — | LOCK|>ZP>H | $6B | |||
| Alibaba Health Information Technology Ltd ALBHF | — | LOCK|H$l%j | $6B | |||
| Raia Drogasil SA ADR RADLY | — | LOCK|!n<$ | $5B | |||
| COSMOS Pharmaceutical Corp CSMYF | — | LOCK|yvw | $3B | |||
| Sugi Holdings Co Ltd SGIPF | — | LOCK|gwK | $3B | |||
| Clicks Group Ltd ADR CLCGY | — | LOCK|DyhCF | $3B | |||
| Clicks Group Ltd CCKRF | — | LOCK|<fQ^D | $3B | |||
| Redcare Pharmacy NV ADR SAEYY | — | LOCK|><B | $2B |
United States